Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
7 Blue-Chip Stocks to Buy for Capital Preservation
02:40pm, Thursday, 23'rd Mar 2023
The financial sector-driven panic sent investors to the refuge of safe assets, including blue-chip stocks. In general, blue-chip stocks have a low beta and this supports capital preservation.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
12:50pm, Thursday, 23'rd Mar 2023 Zacks Investment Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030
09:06am, Thursday, 23'rd Mar 2023 The Motley Fool
These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount.
Investing in Cancer Stocks
03:30am, Thursday, 23'rd Mar 2023 The Motley Fool
Learn about some of the leading cancer stocks in the U.S stock market this year.
Here's What is Driving Amgen (AMGN) Stock's Outperformance
09:51am, Wednesday, 22'nd Mar 2023 Zacks Investment Research
Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline.
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
10:26am, Monday, 20'th Mar 2023 Zacks Investment Research
Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Merck's (MRK) stock afloat in 2023.
Astrazeneca (AZN) Stock Moves -0.56%: What You Should Know
10:00pm, Friday, 17'th Mar 2023 Zacks Investment Research
In the latest trading session, Astrazeneca (AZN) closed at $65.61, marking a -0.56% move from the previous day.
2 Steady Stocks to Buy and Hold Forever
01:45pm, Friday, 17'th Mar 2023 The Motley Fool
Investing in these companies can help you sleep easy at night.
How a nasal vaccine could reduce the risk of COVID infections — and new variants
11:31am, Friday, 17'th Mar 2023 MarketWatch
Three years into the pandemic, the World Health Organization's Joachim Hombach talked with MarketWatch about the future of vaccines.
2 Steady Stocks to Buy and Hold Forever
09:45am, Friday, 17'th Mar 2023
AstraZeneca has all the tools a drugmaker needs to remain a leader in the industry for years. Visa's payment platform is used widely around the world, but it still has room to run.
Astrazeneca (AZN) Could Be a Great Choice
03:45pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
02:22pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
AstraZeneca (AZN) expects total revenues to increase in the low-to-mid single-digit percentage in 2023 at CER.
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
11:28am, Wednesday, 15'th Mar 2023
AstraZeneca (AZN) expects total revenues to increase in the low-to-mid single-digit percentage in 2023 at CER.
Astrazeneca (AZN) Gains As Market Dips: What You Should Know
10:15pm, Monday, 13'th Mar 2023 Zacks Investment Research
Astrazeneca (AZN) closed the most recent trading day at $65.18, moving +1.54% from the previous trading session.
AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies
03:26pm, Friday, 10'th Mar 2023 Zacks Investment Research
Data from late-stage label expansion studies show that AstraZeneca's (AZN) cancer drugs are effective for treating non-small cell lung cancer indications.
